Skip to main content

#157773

Anti-CD160 [CNX46-3]

Cat. #157773

Anti-CD160 [CNX46-3]

Cat. #: 157773

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD160

Class: Monoclonal

Application: FACS ; ELISA ; IP ; WB

Reactivity: Mouse

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BC Cancer

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD160 [CNX46-3]
  • Alternate name: NK28; NK1; BY55
  • Research fields: Immunology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 20 kDa
  • Reactivity: Mouse
  • Host: Rat
  • Application: FACS ; ELISA ; IP ; WB
  • Description: CD160 is found on cytotoxic lymphocytes - NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli.
  • Immunogen: Mouse CD160 fused to FC
  • Immunogen uniprot id: CD160_MOUSE
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: IgG2b kappa

Target Details

  • Target: CD160
  • Molecular weight: 20 kDa
  • Tissue cell line specificity: IgG2b kappa
  • Target background: CD160 is found on cytotoxic lymphocytes - NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli.

Applications

  • Application: FACS ; ELISA ; IP ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Maeda et al. 2005. J Immunol. 175(7):4426-32. PMID: 16177084.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.